ALPHACO CONSULTING LIMITED

Financial Health Score: C- (Borderline Stable)

Explanation: Alphaco Consulting Limited is a patient that has survived a massive financial hemorrhage but is currently in a state of fragile recovery. While the business is technically solvent and showing slight improvements in underlying profitability, it is operating on minimal life support. The cash reserves are dangerously low, and the balance sheet bears the heavy scarring of historical intercompany loans that went bad. The company is surviving, but not thriving.

Key Vital Signs

• Pulse (Cash Position): £2,179 — The patient's pulse is weak but present. Cash has increased slightly from £1,600 in 2023, but it remains far below the £32,484 peak seen in 2021. This indicates a very tight margin for covering day-to-day expenses.
• Blood Pressure (Liquidity Ratio): 3.13x — Current Assets (£15,768) comfortably cover Current Liabilities (£5,033). On the surface, this looks healthy, but the reality is more concerning. The current assets are heavily skewed toward a director's loan and VAT, rather than liquid cash or active trade debtors.
• Weight (Net Assets): £10,735 — The business has gained some healthy weight compared to 2023 (£5,105), but it is a shadow of its former self. In 2021, net assets stood at £85,207, and historically, they were over £300,000. The patient has suffered severe muscle wastage.
• Cholesterol/Blockages (Intercompany Loans): £496,598 (Provisioned) — The balance sheet is severely blocked by loans made to related parties ("Alphaco Investments Limited" and "Alphaco Ltd"). While the gross loans total nearly £500k, they are entirely offset by a provision, meaning the company has accepted this money is likely unrecoverable.

Diagnosis: Post-Hemorrhagic Stabilization with Severe Arterial Blockage

Symptoms Analysis: The financial data reveals a business that underwent a severe financial heart attack in prior years. Historically, the company held substantial net assets (peaking around £500k in 2015-2017). However, cash was drained out of the business through intercompany loans. When those loans became unrecoverable, the company had to write them off, resulting in a massive drop in retained earnings and net assets.

By the end of 2023, the patient was at its weakest point, with net assets of just £5,105 and liabilities (£27,387) dangerously close to swallowing total assets (£32,492).

Current Condition: In 2024, we see signs of stabilization. The Profit and Loss reserve grew from £5,005 to £10,635, indicating the business generated a modest profit of around £5,630 during the year. Liabilities were significantly reduced (down from £27k to just £5k), primarily by clearing a large chunk of corporation tax. However, the underlying trading activity appears minimal—Trade Debtors are only £1,500, suggesting a very low revenue run rate for a consulting firm. The business is currently leaning on a director's loan (£9,162) to stay liquid.

Prognosis: Guarded

The future outlook is guarded. The company has stopped the bleeding and has no immediate threat of insolvency, as current liabilities are very low. However, the business lacks the financial stamina to weather any unexpected storms. The complete provision of the intercompany loans means the "heart" of the business (its cash reserves) cannot be easily restarted without external intervention. Unless the director injects more capital or the business secures new, lucrative consulting contracts, it will remain in a state of financial atrophy.

Recommendations: Prescriptions for Financial Wellness

1. Stimulate Revenue (Cardiovascular Exercise): The company urgently needs to increase its top-line revenue. With trade debtors at only £1,500, the business is practically dormant. Securing new consulting contracts will pump fresh, healthy cash flow through the company's veins.
2. Clear the Arterial Blockage: Investigate the status of the intercompany debtors (Alphaco Investments Limited and Alphaco Ltd). If there is any possibility of recovering even a fraction of these funds, it would act as a massive financial transfusion. If not, ensure the corporate structure is cleaned up to avoid ongoing administrative burden.
3. Cash Resuscitation: Build a minimum cash buffer equivalent to 3-6 months of operating expenses. The current £2,179 is insufficient to handle any unexpected costs or lulls in trade.
4. Director Loan Management: Carefully manage the £9,162 director's loan. If this is money owed to the director, it represents a claim on the company's limited cash. If it is owed by the director, it should be repaid to bolster the company's resilience.